Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment : a Randomized Control Trial

NCT06828640 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Saint Pierre as lead sponsor.

NCT NCT06828640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06828640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment : a Randomized Control Trial
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Phase
Not applicable
Overall status
Recruiting
Start date
October 16, 2024
Completion date
October 31, 2025
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspareunia (female), genitourinary syndrome of menopause (gsm), sexual disfunction, treatment, vaginal atrophy in breast cancer patients, vaginal atrophy patients with gsm, vulvo vaginal atrophy